Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00128635
Status:
COMPLETED
Last Update Posted:
2016-02-19
First Post:
2005-08-08
Brief Title:
Iodine I 131 Monoclonal Antibody TNT-1B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Abramson Cancer Center at Penn Medicine
Organization Data
Organization:
Abramson Cancer Center at Penn Medicine
Class:
OTHER
Study ID:
CDR0000438768
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |